Literature DB >> 472732

Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.

E Cadman, R Heimer, L Davis.   

Abstract

Exposure of L1210 leukemia cells first to 0.1 to 100 micromolar methotrexate and then to 10 micromolar 5-fluorouracil produces a synergistic effect on the number of cells killed in culture. Methotrexate dose-related increases occur in the concentrations of intracellular 5-fluorouracil ribonucleotides and 5-fluoro-2'-deoxyuridylate and in the incorporation of 5-fluorouracil into RNA. These increases are correlated with increased concentrations of intracellular phosphoribosylpyrophosphate. It is proposed that the enhanced formation of ribonucleotides of 5-fluorouracil and the subsequent incorporation of these compounds into RNA in methotrexate-treated cells may account for synergism between these agents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 472732     DOI: 10.1126/science.472732

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  41 in total

1.  Chemotherapy for gastric cancer.

Authors:  A Saini; J Waxman
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

Review 2.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

Authors:  P Ragnhammar; H Blomgren
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

4.  Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case.

Authors:  H Onodera; R Nishitai; K Shimizu; S Maetani; M Imamura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 5.  Drug treatment of colorectal cancer. Current status.

Authors:  L Saltz
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 6.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

7.  Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenografts.

Authors:  K Wayss; R Herrmann; J Mattern; M Volm
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

8.  A 10-year survivor with unresectable hepatic metastases from sigmoid colon carcinoma treated with regional chemotherapy.

Authors:  S Takeda; K Hisatomi; S Nakano; K Okamoto; Y Nagafuchi; H Itoh; K Ohsato
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate.

Authors:  P A Volberding; M A Friedman; K J Resser; T L Phillips
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

10.  Anticancer conjugates and cocktails based on methotrexate and nucleoside synergism.

Authors:  Anthony R Vortherms; Hester N Dang; Robert P Doyle
Journal:  Clin Med Oncol       Date:  2009-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.